| 09/01/2026 3:18 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/28/2026 5:01 PM | Dolby Laboratories (1308547) Issuer Whitten Marc (1848572) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/28/2026 5:02 PM | DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 (1598813) Reporting Dolby Dagmar (1537372) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/27/2026 7:15 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/27/2026 8:00 AM | Dolby Laboratories (1308547) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/25/2026 3:06 PM | Dolby Laboratories (1308547) Subject Nicholson Ryan (1767009) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2026 4:14 PM | Dolby Laboratories (1308547) Issuer Revankar Shriram (1928994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2026 3:30 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/10/2026 3:15 PM | Dolby Laboratories (1308547) Subject Nicholson Ryan (1767009) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/06/2026 4:28 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 4:11 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for DLB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Dolby Laboratories and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/30/2026 3:37 PM | Dolby Laboratories (1308547) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/30/2026 3:15 PM | Dolby Laboratories (1308547) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/06/2026 4:39 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 11:12 AM | BlackRock, Inc. (2012383) Filed by Dolby Laboratories (1308547) Subject | Form SCHEDULE 13G/A | |
| 06/03/2026 3:43 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 4:10 PM | Dolby Laboratories (1308547) Issuer Pendleton Todd (1746636) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 3:18 PM | Dolby Laboratories (1308547) Subject Pendleton Todd (1746636) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/19/2026 4:31 PM | Dolby Laboratories (1308547) Issuer Revankar Shriram (1928994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 6:26 PM | Dolby Laboratories (1308547) Issuer Park Robert J (1887569) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 2:37 PM | Dolby Laboratories (1308547) Subject MORGAN STANLEY (895421) Filed by | Form SCHEDULE 13G/A | |
| 05/06/2026 4:05 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 3:16 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/04/2026 3:19 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/30/2026 3:45 PM | Dolby Laboratories (1308547) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/29/2026 5:24 PM | Dolby Laboratories (1308547) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 11:46 AM | Dolby Laboratories (1308547) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/28/2026 1:02 PM | Bank of New York Mellon Corp (1390777) Filed by Dolby Laboratories (1308547) Subject | Form SCHEDULE 13G/A | |
| 04/03/2026 4:11 PM | Dolby Laboratories (1308547) Issuer Rollins Emily (1847014) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 3:06 PM | Dolby Laboratories (1308547) Subject Rollins Emily (1847014) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 5:03 PM | Dolby Laboratories (1308547) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 4:57 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 5:00 PM | Dolby Laboratories (1308547) Issuer Revankar Shriram (1928994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:33 PM | Dolby Dagmar (1537372) Filed by Dolby Laboratories (1308547) Subject | Form SCHEDULE 13D/A | |
| 02/11/2026 10:42 AM | Dolby Laboratories (1308547) Subject MORGAN STANLEY (895421) Filed by | Form SCHEDULE 13G/A | |
| 02/09/2026 3:19 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:15 PM | Dolby Laboratories (1308547) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/05/2026 6:44 PM | Dolby Laboratories (1308547) Issuer Sud Anjali (1775509) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:46 PM | Dolby Laboratories (1308547) Issuer GOTCHER PETER C (935901) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:47 PM | Dolby Laboratories (1308547) Issuer Rollins Emily (1847014) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:50 PM | Dolby David (1511370) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
The $15 Gold Fund That Pays Up to $1,152/Month (Ad) Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. Discover the gold income fund before the next payout date |
| 02/05/2026 6:52 PM | Dolby Laboratories (1308547) Issuer Segars Simon (1632353) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:40 PM | Dolby Laboratories (1308547) Issuer TEVANIAN AVADIS (1214091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:42 PM | Dolby Laboratories (1308547) Issuer Prophet Tony A (1588813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:10 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 4:55 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/29/2026 3:57 PM | Dolby Laboratories (1308547) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 01/29/2026 3:15 PM | Dolby Laboratories (1308547) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/17/2025 8:44 PM | Dolby Laboratories (1308547) Issuer Pendleton Todd (1746636) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:46 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:48 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:38 PM | Dolby Laboratories (1308547) Issuer Park Robert J (1887569) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:39 PM | Dolby Laboratories (1308547) Issuer SHERMAN MARK ANDREW (1256708) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:41 PM | Dolby Laboratories (1308547) Issuer Revankar Shriram (1928994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:43 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 3:10 PM | Dolby Laboratories (1308547) Subject SHERMAN MARK ANDREW (1256708) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/17/2025 3:07 PM | Dolby Laboratories (1308547) Subject YEAMAN KEVIN J (1200469) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:38 PM | Dolby Laboratories (1308547) Subject SHERMAN MARK ANDREW (1256708) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:47 PM | Dolby Laboratories (1308547) Subject YEAMAN KEVIN J (1200469) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 7:44 AM | Dolby Laboratories (1308547) Filer | Form ARS | |
| 12/16/2025 7:30 AM | Dolby Laboratories (1308547) Filer | Form DEF 14A | |
| 12/16/2025 7:32 AM | Dolby Laboratories (1308547) Filer | Form DEFA14A | |
| 12/15/2025 4:03 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 4:04 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 3:04 PM | Dolby Laboratories (1308547) Subject YEAMAN KEVIN J (1200469) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/03/2025 5:55 PM | Dolby Laboratories (1308547) Issuer SHERMAN MARK ANDREW (1256708) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 7:37 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 3:27 PM | Dolby Laboratories (1308547) Issuer Prophet Tony A (1588813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 3:32 PM | Dolby Laboratories (1308547) Subject YEAMAN KEVIN J (1200469) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/24/2025 3:44 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 3:07 PM | Dolby Laboratories (1308547) Subject Revankar Shriram (1928994) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/20/2025 3:09 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 4:01 PM | Dolby Laboratories (1308547) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 10/16/2025 7:24 PM | Dolby Laboratories (1308547) Issuer Park Robert J (1887569) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2025 7:15 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2025 4:23 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 3:09 PM | Dolby Laboratories (1308547) Subject YEAMAN KEVIN J (1200469) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |